Clascoterone Cream 1%

DRUG3 trials

Sponsors

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd., Narrows Institute for Biomedical Research, Khyber Teaching Hospital

Conditions

Acne VulgarisPapular-pustular RosaceaPapulopustular RosaceaPapulopustular Rosacea (PPR)

Early Phase 1

Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris

Not yet recruitingNCT07673094

Khyber Teaching HospitalAcne Vulgaris

Start: 2026-08-15End: 2027-08-22Target: 60Updated: 2026-06-29

Phase 1

Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

CompletedNCT06454708

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.Acne Vulgaris

Start: 2024-08-01End: 2024-08-12Updated: 2025-01-28

Phase 2

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

RecruitingNCT06952517

Narrows Institute for Biomedical ResearchPapular-pustular Rosacea, Papulopustular Rosacea, Papulopustular Rosacea (PPR)

Start: 2025-03-14End: 2025-09-30Target: 20Updated: 2025-05-06